-
81
Structure- and machine learning-guided engineering demonstrate that a non-canonical disulfide in an anti-PD-1 rabbit antibody does not impede antibody developability
Published 2024-12-01Subjects: “…Programmed cell death (PD-1)…”
Get full text
Article -
82
A network comparison on efficacy and safety profiling of PD-1/PD-L1 inhibitors in first-line treatment of advanced non-small cell lung cancer
Published 2025-01-01Subjects: Get full text
Article -
83
Efficacy and safety of first-line PD-1/PD-L1 inhibitor in combination with CTLA-4 inhibitor in the treatment of patients with advanced non-small cell lung cancer: a systemic review...
Published 2025-02-01Subjects: “…PD-1 inhibitor…”
Get full text
Article -
84
Illuminating the impact of CD38-induced adenosine formation in B-cell lymphoma
Published 2025-01-01Subjects: Get full text
Article -
85
-
86
Suppression of MCP-1, IFN-γ and IL-6 production of HNSCC ex vivo by pembrolizumab added to docetaxel and cisplatin (TP) exceeding those of TP alone is linked to improved survival
Published 2025-01-01Subjects: “…PD-1:PD-L1 immune-checkpoint inhibitor (ICI) pembrolizumab…”
Get full text
Article